MoneyWorks4Me

Bliss GVS Pharma informs about disclosure

28 Dec 2018 Evaluate

Bliss GVS Pharma has informed about the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsimha Shibroor Kamath.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.10
Dr. Reddys Labs. 1153.15
Cipla 1357.05
Lupin 2056.55
Zydus Lifesciences 1109.90
View more..